Over the last 2 decades, negative-pressure wound therapy (NPWT) has been successfully applied to the treatment of various wounds. Recently, as a result of the development of a more-refined NPWT system, a silver-containing polyurethane open-cell foam has been introduced. The aim was to demonstrate the antibacterial efficacy of silver-impregnated NPWT compared to conventional NPWT when applied on open contaminated wounds of the lower extremities. We designed a prospective, double-blind, randomized controlled trial at 2 tertiary center institutions comparing the 2 types of NPWT in acute traumatic lower extremity ulcers with exposed soft tissue deeper than the deep dermis. Subjects were randomly allocated into either an experimental group treated with silver-impregnated NPWT or a control group treated with conventional NPWT, then the study wounds were administered NPWT at initial presentation. Wound cultures for all patients were obtained serially for semiquantitative analysis on a weekly basis during dressing changes. The cultures were serially obtained from 4 sites: wound surface (wound swab), deepest granulation tissue of the wound (tissue culture), end of the suction tube connected to sealed film, and a portion of polyurethane foam sponge surfacing on the wound. The primary outcomes of interest were bioburden reduction and rate of bacterial growth in the 2 groups, which were evaluated according to "rate of culture positivity" each week. Another important measure was the identification and transition of 4 specific bacterial species that are most commonly encountered in clinical settings, *Staphylococcus aureus*, methicillin-resistant *S. aureus* (MRSA), *Pseudomonas*, and *Acinetobacter* species. Ultimately, 66 wounds in 66 patients were analyzed by this study. The mean duration of NPWT application was 29.9 ± 10.7 days. Of the 66 wounds, 31 wounds were allocated to the conventional NPWT group (31 patients: 23 men and 8 women) and 35 wounds to the silver NPWT group (35 patients: 29 men and 6 women). In the conventional NPWT group, the mean age was 48.5 years and the mean wound size was 260 ± 563 cm^2^. The mean duration of NPWT application was 37.6 ± 7.6 days. In the silver NPWT group, the mean age was 46.5 years and the mean wound size was 233 ± 346 cm^2^. Throughout the study period, no significant complications or adverse events were observed. For MRSA, the silver-impregnated group showed a significant reduction with culture positivity rate on wound surface (at second week, *P* = 0.010; at third week, *P* = 0.031; and at final week, *P* = 0.048) and tissue (at second week, *P* = 0.030; at third week, *P* = 0.058; and at final week, 0.076---marginal borderline at third and final week). The MRSA-positive rate in the silver group showed a steady decline over time, with statistical significance. In addition, the MRSA colonization rate in the silver group was lower than in the conventional NPWT group in all locations, with statistically significant differences in wound surface and tissue culture. This randomized study has indicated that silver-impregnated NPWT is more effective for bacterial clearance, especially for MRSA, than conventional NPWT.
